These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 31143068)

  • 1. Inflammatory bowel diseases and spondyloarthropathies: From pathogenesis to treatment.
    Fragoulis GE; Liava C; Daoussis D; Akriviadis E; Garyfallos A; Dimitroulas T
    World J Gastroenterol; 2019 May; 25(18):2162-2176. PubMed ID: 31143068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seronegative spondyloarthropathy-associated inflammatory bowel disease.
    Wang CR; Tsai HW
    World J Gastroenterol; 2023 Jan; 29(3):450-468. PubMed ID: 36688014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut inflammation in the spondyloarthropathies.
    Mielants H; De Keyser F; Baeten D; Van den Bosch F
    Curr Rheumatol Rep; 2005 Jun; 7(3):188-94. PubMed ID: 15918994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common immunologic mechanisms in inflammatory bowel disease and spondylarthropathies.
    Fantini MC; Pallone F; Monteleone G
    World J Gastroenterol; 2009 May; 15(20):2472-8. PubMed ID: 19468997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory bowel disease manifestations in spondyloarthritis: considerations for the clinician.
    Lubrano E; Luchetti MM; Benfaremo D; Mauro D; Ciccia F; Perrotta FM
    Expert Rev Clin Immunol; 2021 Nov; 17(11):1199-1209. PubMed ID: 34622735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal lesions associated with spondyloarthropathies.
    Orlando A; Renna S; Perricone G; Cottone M
    World J Gastroenterol; 2009 May; 15(20):2443-8. PubMed ID: 19468992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The joint-gut axis in inflammatory bowel diseases.
    Brakenhoff LK; van der Heijde DM; Hommes DW; Huizinga TW; Fidder HH
    J Crohns Colitis; 2010 Sep; 4(3):257-68. PubMed ID: 21122514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic and genetic links between spondylarthropathies and inflammatory bowel diseases.
    Faustini F; Zoli A; Ferraccioli GF
    Eur Rev Med Pharmacol Sci; 2009 Mar; 13 Suppl 1():1-9. PubMed ID: 19530505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current issues in pediatric inflammatory bowel disease-associated arthropathies.
    Cardile S; Romano C
    World J Gastroenterol; 2014 Jan; 20(1):45-52. PubMed ID: 24415857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut inflammation and spondyloarthropathies.
    De Keyser F; Baeten D; Van den Bosch F; De Vos M; Cuvelier C; Mielants H; Veys E
    Curr Rheumatol Rep; 2002 Dec; 4(6):525-32. PubMed ID: 12427369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheumatic manifestations in inflammatory bowel disease.
    Atzeni F; Defendenti C; Ditto MC; Batticciotto A; Ventura D; Antivalle M; Ardizzone S; Sarzi-Puttini P
    Autoimmun Rev; 2014 Jan; 13(1):20-3. PubMed ID: 23774109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of gut inflammation in the pathogenesis of spondyloarthropathies.
    Mielants H; De Vos M; Cuvelier C; Veys EM
    Acta Clin Belg; 1996; 51(5):340-9. PubMed ID: 8950841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spondyloarthropathy in inflammatory bowel disease patients on TNF inhibitors.
    Subramaniam K; Tymms K; Shadbolt B; Pavli P
    Intern Med J; 2015 Nov; 45(11):1154-60. PubMed ID: 26337851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of intestinal inflammation in the pathogenesis of spondylarthropathies].
    Mielants H; Veys EM
    Verh K Acad Geneeskd Belg; 1996; 58(2):93-116. PubMed ID: 8768479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease.
    Turkcapar N; Toruner M; Soykan I; Aydintug OT; Cetinkaya H; Duzgun N; Ozden A; Duman M
    Rheumatol Int; 2006 May; 26(7):663-8. PubMed ID: 16136311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease].
    Kujundzić M
    Acta Med Croatica; 2013 Apr; 67(2):195-201. PubMed ID: 24471303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute anterior uveitis and other extra-articular manifestations of spondyloarthritis.
    Mitulescu TC; Popescu C; Naie A; Predeţeanu D; Popescu V; Alexandrescu C; Voinea LM
    J Med Life; 2015; 8(3):319-25. PubMed ID: 26351533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease.
    Olivieri I; Cantini F; Castiglione F; Felice C; Gionchetti P; Orlando A; Salvarani C; Scarpa R; Vecchi M; Armuzzi A
    Autoimmun Rev; 2014 Aug; 13(8):822-30. PubMed ID: 24726868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune linkages between inflammatory bowel disease and spondyloarthropathies.
    Baeten D; De Keyser F; Mielants H; Veys EM
    Curr Opin Rheumatol; 2002 Jul; 14(4):342-7. PubMed ID: 12118165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Course of gut inflammation in spondylarthropathies and therapeutic consequences.
    Mielants H; Veys EM; Cuvelier C; De Vos M
    Baillieres Clin Rheumatol; 1996 Feb; 10(1):147-64. PubMed ID: 8674145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.